ARGFX
Arginine-fifty homeobox
Also known as: ARGFX_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NJG6
- Gene
- ARGFX
- Ensembl
- ENSG00000186103
- Chromosome
- 3
- Canonical length
- 315 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
Homeobox genes encode DNA-binding proteins, many of which are thought to be involved in early embryonic development. Homeobox genes encode a DNA-binding domain of 60 to 63 amino acids referred to as the homeodomain. This gene is a member of the ARGFX homeobox gene family. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
315 residues, UniProt reviewed canonical sequence.
>A6NJG6|ARGFX
1 MRNRMAPENP QPDPFINRNY SNMKVIPPQD PASPSFTLLS KLECSGTVSA YCSLNLPGST
61 DPPTSASRVA ATTAIRRRHK ERTSFTHQQY EELEALFSQT MFPDRNLQEK LALRLDLPES
121 TVKVWFRNRR FKLKKQQQQQ SAKQRNQILP SKKNVPTSPR TSPSPYAFSP VISDFYSSLP
181 SQPLDPSNWA WNSTFTESST SDFQMQDTQW ERLVASVPAL YSDAYDIFQI IELYNLPDEN
241 EISSSSFHCL YQYLSPTKYQ VGGQGSSLSI FAGPAVGLSP AQTWPNMTSQ AFEAYSLTDS
301 LEFQKTSNMV DLGFLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARGFX can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 1 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 1 nTPM
- skin: 0.6 nTPM
- retina: 0.5 nTPM
- skeletal muscle: 0.4 nTPM
- lymph node: 0.3 nTPM
- pancreas: 0.3 nTPM
Single-cell type
- cardiomyocytes: 49 nCPM
- myonuclei: 10 nCPM
- sertoli cells: 3.4 nCPM
- thymic myoid cells: 2.7 nCPM
- plasma cells: 2.2 nCPM
- epididymal basal cells: 1.1 nCPM
Immune cell
- neutrophil: 1.6 nTPM
- basophil: 1.2 nTPM
- naive B-cell: 0.5 nTPM
- NK-cell: 0.5 nTPM
- classical monocyte: 0.4 nTPM
- memory B-cell: 0.4 nTPM
Brain region
- cerebellum: 11 nTPM
- white matter: 9.7 nTPM
- cerebral cortex: 8.4 nTPM
- pons: 7.9 nTPM
- basal ganglia: 7.8 nTPM
- choroid plexus: 7.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.85
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.16
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARGFX as an antibody target. Whether an autoantibody or antibody against ARGFX could matter depends on whether native ARGFX is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARGFX is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARGFX as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...